New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives
ABR News

New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives

Antibiotics are crown to the modern medicine, and they are the weapon against numerous infectious diseases. The exposure of bacteria to ‘non-lethal levels’ of antibiotics is causing antibiotic resistance (ABR) in them. Multidrug resistance (MDR) is the most common type of resistance. The MDR refers to bacteria showing resistance to…

Comments Off on New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives
March 12, 2022
Discovery of Actinomycin L, A New Member of the Actinomycin Family of Antibiotics
ABR News

Discovery of Actinomycin L, A New Member of the Actinomycin Family of Antibiotics

Antibiotic resistance is the major emerging crisis that escalates among the pathogen. Hence newer, less toxic and efficient drugs remains the top priority. The majority source of antibiotics in use today is from Actinobacteria and the antibiotic identified is Actinomycin. Streptomyces’s is the crucial bioactive natural product producer that includes…

Comments Off on Discovery of Actinomycin L, A New Member of the Actinomycin Family of Antibiotics
March 3, 2022
A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India
ABR News

A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India

The Global Action Plan is one of the key initiatives by the World Health Organization (WHO) to combat the increasing incidence of antimicrobial resistance (AMR). In this direction, WHO has articulated a list of pathogens under the umbrella of ‘priority pathogens’ to provide strategic direction to research and develop new…

0 Comments
June 11, 2021